Improving Quality Through Public Disclosure Of Performance Information
- 1 July 2002
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 21 (4) , 52-62
- https://doi.org/10.1377/hlthaff.21.4.52
Abstract
The period from the 1980s to the present has witnessed a lively and unsettled debate concerning the legalization of marijuana, cocaine, heroin, and other illicit substances in the United States. Proponents of legalization argue that the demand for these harmful and potentially addictive substances is not responsive to price. Opponents argue that prices will fall tremendously in a regime characterized by legalization and that the option of legalization and taxation is not feasible. In this paper we summarize theoretical and empirical evidence suggesting that none of these propositions is correct.Keywords
This publication has 36 references indexed in Scilit:
- No Toyotas In Health Care: Why Medical Care Has Not Evolved To Meet Patients’ NeedsHealth Affairs, 2001
- Creating, connecting and supporting active consumersJournal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 2001
- How Good Is the Quality of Health Care in the United States?The Milbank Quarterly, 1998
- Quality of Care Information Makes a DifferenceMedical Care, 1998
- Choosing a Health Plan: Do Large Employers Use the Data?Health Affairs, 1997
- Public release of cardiac surgery outcomes data in New York: What do New York state cardiologists think of it?American Heart Journal, 1997
- Choosing A Health Plan: What Information Will Consumers Use?Health Affairs, 1997
- Legibility and completeness of physicians' handwritten medication ordersHeart & Lung, 1997
- The decline in coronary artery bypass graft surgery mortality in New York State. The role of surgeon volumeJAMA, 1995
- How often is medication taken as prescribed? A novel assessment techniqueJAMA, 1989